Golidocitinib Plus CHOP in Newly Diagnosed PTCL

Clinical trial NCT06739265 · RECRUITING

Trial details

NCT number: NCT06739265
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma

Start date: 2024-09-01
Primary completion: 2026-09-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.